SCHEMBL7401623

SCHEMBL7401623

CCCCN1CCC(C2(C)COc3c(C(=O)O)ccc(N)c3O2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 14/20 0.52
HTR2C P28335 3/20 0.40
ADRA2C P18825 3/20 0.40
HTR1D P28221 3/20 0.40
HTR2B P41595 3/20 0.40
ADRA1A P35348 2/20 0.40
ADRA1B P35368 2/20 0.40
ADRA2B P18089 1/20 0.40
HTR3A P46098 3/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
LMNA P02545 1/20 0.39
ADRA2A P08913 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404754 0.85 HTR4 (0.54) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL7405655 0.84 HTR4 (0.50) HTR4ADRA1AADRA1BADRA2BADRA2A
Hydrochloric Acid SCHEMBL7399148 0.84 HTR2C (0.54) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL7395283 0.79 HTR4 (0.39) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL8317705 0.79 HTR4 (0.41) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL8461663 0.79 HTR4 (0.54) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL7401627 0.75 HTR4 (0.56) HTR4HTR2CADRA2CHTR1DHTR2B
SCHEMBL8321575 0.72 HTR4 (0.48) HTR4ADRA1AADRA1BADRA2BADRA2A
Hydrochloric Acid SCHEMBL7498484 0.71 HTR4 (0.47) HTR4ADRA1AADRA1BADRA2BADRA2A
SCHEMBL7398142 0.69 HTR4 (0.46) HTR4HTR2CADRA2CHTR1DHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604494-B1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1999-07-28 EP claimed
US-5580885-A FOR TREATMENT OF GASTROINTESTINAL, CARDIOVASCULAR OR NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 1996-12-03 US claimed
EP-0604494-B1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1999-07-28 EP disclosed
US-5580885-A FOR TREATMENT OF GASTROINTESTINAL, CARDIOVASCULAR OR NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 1996-12-03 US disclosed
EP-0604494-A1 5-HT 4? RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-07-06 EP disclosed
WO-1993005038-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-03-18 WO disclosed